Search Results 1651-1660 of 20693 for Informed consent

1. A Trial of the Effectiveness and Safety of CVL-865 to Treat Focal Onset Seizures - Mayo Clinic

   ... informed consent throughout the duration of the study and for 30 days post last dose. A male subject with a pregnant or a nonpregnant partner of ...

2. Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma - Mayo Clinic

   ... informed consent for the study. Subject is ≥18 years of age on the day of signing the informed consent. Have a history of histologically- or cytologically ...

3. Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer - Mayo Clinic

   * REGISTRATION: Provide written informed consent * REGISTRATION: Ability to complete questionnaire(s) by themselves or with assistance * REGISTRATION ...

4. Pilot Open-Label Trial Of Resistant Potato Starch In Patients With Cirrhosis And Overt Hepatic Encephalopathy - Mayo Clinic

   Able to provide consent for self, with signed and dated informed consent form. Stated willingness to comply with all study procedures and availability for ...

5. Electroconvulsive Therapy in Severe Agitation in Alzheimer's Dementia - Mayo Clinic

   Authorized legal representative able and willing to give informed consent. Age 55 - 89 years old (inclusive). Exclusion Criteria: Current ...

6. A Study to Evaluate NPC-21 to Treat Kidney Transplant Patients at High Risk for Cytomegalorvirus Infection - Mayo Clinic

   ... informed consent. Patients must be CMV seronegative pre-transplant and ... Patients must be willing and able to give written informed consent for participation in ...

7. A Study to Evaluate the Safety and Effectiveness of Obeticholic Acid Treatment on People with Non-Alcoholic Steatohepatitis with Fibrosis - Mayo Clinic

   Must provide written informed consent and agree to comply with the study protocol. ... Mental instability or incompetence, such that the validity of informed ...

8. Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma - Mayo Clinic

   Participants must be informed of the investigational nature of this study and must sign and give informed consent in accordance with institutional and federal ...

9. A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

   Subject must be able and willing to give written informed consent and to comply with the requirements of this study protocol. In Japan, if the subject is ...

10. Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery - Mayo Clinic

    ... informed consent through 90 days (for female patients) and 120 day (for male patients) after the last dose of study drug, or agree to completely abstain ...